TERESA AMENT: Open Payments
NPI 1326156712 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 15 payments from 7 companies in 2025. Trend: 2023 $160 · 2024 $510 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $117 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Corium, LLC | 4 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Neos Therapeutics, LP | 1 | $15 |
Products named: INVEGA SUSTENNA, REXULTI, CAPLYTA, Azstarys, HETLIOZ, UZEDY, Adzenys XR-ODT.
Industry payments across TN — which companies pay providers there.
